Thursday, August 11, 2022
Home News Pharma News

Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

WHO recommends cabotegravir for HIV prevention

WHO recommends cabotegravir for HIV prevention

New WHO guidelines recommend countries implement cabotegravir into their HIV prevention strategy. The World Health Organization (WHO) has released new guidelines for cabotegravir (CAB-LA) and...
NHS saves £1.2 billion of taxpayer money on cutting-edge medications

NHS saves £1.2 billion of taxpayer money on cutting-edge medications

In a new press release, the NHS has stated they have saved £1.2bn on life-changing medications by securing cost-effective deals. The NHS has announced that...
Scientists develop innovative non-opioid pain killer

Scientists develop innovative non-opioid pain killer

Scientists from the University of Warwick have developed a non-opioid pain killer with minimal side effects. Opioids are a class of drugs that work to...
WHO: Alarming data shows childhood vaccinations are declining

WHO: Alarming data shows childhood vaccinations are declining

Official data from WHO and UNICEF finds the largest sustained decline in childhood vaccinations in around 30 years. In the UK, children up to 15...
insulin therapy

S100A9 protein may provide an alternative to insulin therapy

University of Geneva (UNIGE) scientists have demonstrated that the S100A9 protein can be developed into an effective diabetes treatment and could one day replace...
NICE recommends two new affordable breast cancer treatments

NICE recommends two new affordable breast cancer treatments

NICE has agreed to an affordable deal for two breast cancer treatments, available immediately to patients on the NHS. In the final draft guidance, NICE...
NICE approves first new mesothelioma cancer treatment in 15 years

NICE approves first new mesothelioma cancer treatment in 15 years

Exciting news arrives from the NHS as they announce the first treatment for mesothelioma cancer in over a decade is now approved. This new treatment...
Implementing an antibiotic subscription model into the UK healthcare system

Extending the UK’s leadership with an antibiotic subscription model to tackle AMR

Following the UK’s top ranking in the recent AMR Preparedness Index, Michael Hodin and Peter Jackson discuss the country’s novel antibiotic subscription model and...
alpelisib

Alpelisib becomes 100th fast tracked NHS cancer drug

Alpelisib – a life-extending drug for patients with advanced breast cancer – has become the 100th fast-tracked cancer drug on the NHS and will...
nerve damage

Experimental drug repairs nerve damage from spinal cord injury

A groundbreaking study from the University of Birmingham has shown that a candidate drug called AZD1390 can repair nerve damage following a spinal cord...
Microdosing psilocybin

Microdosing psilocybin shows effectiveness in improving mental health

Evidence from a University of British Colombia investigation suggests that microdosing psilocybin may be an effective treatment for mental health conditions. The Microdose.me project, published in...
New universal influenza B vaccine offers extensive protection

New universal influenza B vaccine offers extensive protection

A new universal influenza B vaccine offers a strong defence against different strains and improved immune protection. A new study by biomedical scientists from the Institute...
treatments for HIV

Protein discovery may create new treatments for HIV

Scientists have uncovered the mechanism behind a crucial protein that causes HIV to spread. The findings may help to develop novel treatments for HIV. Researchers...
weight loss drug

Fat burning peptide may help to design an effective weight loss drug

Brazilian scientists have demonstrated that a new peptide has powerful anti-obesity properties in a rodent study and may help develop a potent weight loss...
ADHD medications

Common ADHD medications may treat Alzheimer’s disease

An extensive data analysis has revealed that widely used ADHD medications may be effective at reducing the impact of Alzheimer’s disease. The investigation examined the...
Broadening the availability of orphan drugs

Broadening the availability of orphan drugs

Ahead of the EU’s revision of the regulatory framework governing orphan drugs, we spoke to the European Medicines Agency about some of the key...
Down syndrome

Lamivudine HIV drug improves Down syndrome cognitive impairment

An antiretroviral drug that is traditionally used to treat HIV – known as lamivudine – has been shown to improve cognitive abilities in a...
Scientists create a vaccine basis for a common pollen allergy

Scientists create a vaccine basis for a common pollen allergy

New research could mean scientists are getting closer to a vaccine for mugwort, a common pollen allergy. A research team at MedUni Vienna has discovered...
New targeted treatment for early-stage breast cancer available on NHS

New targeted treatment for early-stage breast cancer available on NHS

Provisional approval by NICE could see a step-change in treatment for early-stage breast cancer following surgery. The National Institute of Health and Care Excellence (NICE)...
NHS treats first sickle cell disease patients with new drug

NHS treats first sickle cell disease patients with new drug

One of the first sickle cell disease patients has received a life-changing drug called crizanlizumab, the first new treatment for the disease in over...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest